Articles From: Horizon Pharma plc Announces Clinical Data on RAYOS(R) (Prednisone) Delayed-Release Tablets and VIMOVO(R) (Naproxen/Esomeprazole Magnesium) to Be Presented at the American College of Rheumatology Annual Meeting to BioSpecifics Technologies Corp. to Present at the Stifel 2014 Healthcare Conference


http://media.marketwire.com/attachments/201411/81703_horizonpharma.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1158415&ProfileId=051205&sourceType=1 DUBLIN, IRELAND --
Sign-up for Horizon Pharma plc Announces Clinical Data on RAYOS(R) (Prednisone) Delayed-Release Tablets and VIMOVO(R) (Naproxen/Esomeprazole Magnesium) to Be Presented at the American College of Rheumatology Annual Meeting investment picks
Dillard’s, Inc. (NYSE: DDS) will announce results for the 13 and 39 weeks ended November 1, 2014 before the open of the New York Stock Exchange tomorrow, Thursday, November 13 th .
Sign-up for Dillard’s, Inc. to Report Third Quarter Results investment picks
BEACHWOOD, Ohio , Nov.
Sign-up for DDR Exits Joint Venture in Buffalo investment picks
REDWOOD CITY, Calif., Nov.
Sign-up for Dermira Reports Third Quarter 2014 Financial Results and Provides Corporate Update investment picks
GREENSBORO, N.C. , Nov.
Sign-up for Tanger Prices $250 Million 3.75% Senior Notes Due 2024 investment picks
Silicon Labs (NASDAQ: SLAB), a leading provider of wireless connectivity solutions for the Internet of Things , today introduced next-generation EZRadio ® and EZRadioPRO ® wireless ICs offering industry-leading power efficiency, wireless range and flexibility.
Sign-up for Silicon Labs Expands Sub-GHz Wireless Portfolio to Support 802.15.4/4g Connectivity investment picks
MOUNTAIN VIEW, Calif.
Sign-up for Synopsys Announces Earnings Release Date for Fourth Quarter and Fiscal Year 2014 investment picks
CHARLESTON, S.C., Nov.
Sign-up for Benefitfocus to Present at the Goldman Sachs US Emerging/SMID Cap Growth Conference investment picks
http://media.marketwire.com/attachments/201211/98749_netapp.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1158372&ProfileId=051205&sourceType=1 SUNNYVALE, CA --
Sign-up for NetApp Accelerates Customers' Use of the Cloud With New Products on Amazon Web Services investment picks
The Marketing Alliance, Inc. (OTC: MAAL) (“TMA”), today announced that its Board of Directors authorized a $0.21 per share cash dividend for shareholders of record on December 12, 2014, to be paid on or about January 30, 2015.
Sign-up for The Marketing Alliance Announces Annual Cash Dividend of $0.21 Per Share investment picks
Sophiris Bio Inc. (NASDAQ: SPHS) (the “Company” or “Sophiris”), a biopharmaceutical company developing PRX302 for the treatment of the symptoms of benign prostatic hyperplasia (BPH, enlarged prostate) and for the treatment of localized low to intermediate risk prostate cancer, today announced financial results for the three and nine months ended September 30, 2014.
Sign-up for Sophiris Bio Reports Third Quarter Financial Results investment picks
CBRE Group, Inc. (NYSE:CBG) has been awarded the H.
Sign-up for CBRE Group, Inc. Receives Prestigious Global Innovators Award from CoreNet Global investment picks
Griffon Corporation (“Griffon” or the “Company”) (NYSE:GFF) today reported results for the fourth quarter and fiscal year ended September 30, 2014.
Sign-up for Griffon Corporation Announces Fourth Quarter and Annual Results investment picks
LAKE FOREST, Ill., Nov.
Sign-up for Stericycle to Present at NASDAQ Conference in December investment picks
COMMERCE, Calif.
Sign-up for Smart & Final Stores, Inc. Reports Third Quarter 2014 Results investment picks
– Confirmation of Plans to Initiate Phase 2 Active Comparator Study for RT002 in 2014 – NEWARK, Calif., Nov.
Sign-up for Revance Therapeutics Releases Third Quarter 2014 Results investment picks
GAINESVILLE, Fla., Nov.
Sign-up for AGTC Announces Financial Results for the First Quarter Ended September 30, 2014 investment picks
NEW BRUNSWICK, N.J. , Nov.
Sign-up for Magyar Bancorp, Inc. Announces Fourth Quarter And Year End Financial Results investment picks
RANCHO CUCAMONGA, Calif., Nov.
Sign-up for Amphastar Pharmaceuticals Reports Revenues of $59.7 Million for the Third Quarter Ended September 30, 2014 investment picks
http://media.marketwire.com/attachments/201409/79276_MarathonLogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1158176&ProfileId=051205&sourceType=1 ALEXANDRIA, VA --
Sign-up for Marathon Patent Group, Inc. Announces Strong Third Quarter 2014 Financial Results investment picks
Brown Shoe Company (NYSE: BWS)( brownshoe.com ) today announced it plans to release its third quarter 2014 financial results before market open on Tuesday, November 25.
Sign-up for Brown Shoe Company Announces Time for Third Quarter 2014 Earnings Call investment picks
Cherry Hill Mortgage Investment Corporation (NYSE:CHMI) (“Cherry Hill” or the “Company”), today reported results for the third quarter of 2014.
Sign-up for Cherry Hill Mortgage Investment Corporation Announces Third Quarter 2014 Results investment picks
La Jolla Pharmaceutical Company (NASDAQ: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, today reported third quarter and year-to-date 2014 financial results and highlighted recent corporate progress and near-term milestones.
Sign-up for La Jolla Pharmaceutical Company Announces Third Quarter and Year-to-Date 2014 Financial Results and Corporate Highlights investment picks
Synta Pharmaceuticals Corp.
Sign-up for Synta to Present at the Stifel 2014 Healthcare Conference investment picks
LYNBROOK, N.Y. , Nov.
Sign-up for BioSpecifics Technologies Corp. to Present at the Stifel 2014 Healthcare Conference investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Horizon Pharma plc Announces Clinical Data on RAYOS(R) (Prednisone) Delayed-Release Tablets and VIMOVO(R) (Naproxen/Esomeprazole Magnesium) to Be Presented at the American College of Rheumatology Annual Meeting to BioSpecifics Technologies Corp. to Present at the Stifel 2014 Healthcare Conference
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent